News Sentiment

DMRA sentiment intelligence

Damora Therapeutics, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 38 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 31.48 Week of 17 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

82/100 classification confidence.

Company focus 29

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+10.3% over one week, +48.3% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Top Damora Therapeutics, Inc. Common Stock (DMRA) Competitors 2026

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 82/100 classification
One-week reaction 10.3% Price confirming higher
Trend fit Trend inactive 48.3% over four weeks
Fair value 112.3% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 30
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 29
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 8
Stock Titan 7
MarketBeat 4
MT Newswires 4
simplywall.st 3
TradingView 3
Investing.com Nigeria 2
GlobeNewswire 2

Event Lens

What the news is about

Classified themes
Market update 22
Earnings 11
Analyst action 3
Guidance 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 38